A provincial law passed in December would force at least 10 of Ontario's 17 sites to close by March 31. Can it be stopped?

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

New medicines are being developed for individual treatments based on someone’s DNA. Those would be allowed under a proposed ...

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

In an extraordinary act of courage, Ms Patchani Phunsuk, a whistleblower at the heart of a pharmaceutical corruption scandal, ...

The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...